期刊文献+

抗PSMA7单克隆抗体的制备和初步鉴定 被引量:4

Preparation and identification of the monoclonal antibody against human PSMA7 antigen
下载PDF
导出
摘要 目的制备抗蛋白酶体α7亚基(PSMA7)的单克隆抗体,为PSMA7的功能研究奠定基础。方法以纯化的重组蛋白PSMA7为抗原免疫BALB/c小鼠,运用杂交瘤技术制备PSMA7单克隆抗体,并用间接ELISA法和Western blot法对单克隆抗体的特性进行鉴定。结果成功建立两株稳定分泌抗PSMA7蛋白的单克隆抗体杂交瘤细胞株,分别命名为B013和B001。检测杂交瘤细胞培养上清抗体效价为1∶128和1∶256,腹水效价为1∶25600和1∶32000。两株单克隆抗体的免疫球蛋白亚类均为IgG1。Westernblot及免疫组化实验证实,两株单克隆抗体均能特异性结合真核细胞内源性PSMA7蛋白。结论成功建立了两株效价高、特异性好的抗PSMA7单克隆抗体杂交瘤细胞,制备的单克隆抗体可用于PSMA7蛋白的鉴定,为其生物学功能研究奠定了基础。 Objeetive To prepare the PSMA7 hybridoma cell lines using classical hybridoma technique and to perform purification and elementary identification of the monoclonal antibodies (McAbs) against PSMA7 antigen for further study. Methods BALB/c mice were immunized with purified recombinant PSMA7 protein. Once the antibody titer of blood taken from mouse tail reached 1 : 6 400, a cell fusion was performed between mouse splenic cells and myeloma cells (Sp2/0), and then the hybridorna cell lines secreting monoclonal antibodies against PSMA7 antigen were screened by indirect enzyme linked immunosorbent assay (ELISA). The immunoglobulin subtypes and titer of the monoclonal antibodies against PSMA7 antigen were identified and measured by Western blot analysis and enzyme linked immunosorbent assay, respectively. Results After cell fusion and subcloning, two hybridoma cell lines that stably secreted monoclonal antibodies against PSMA7 antigen were successfully obtained: 13013 and 13001, which belong to the subtypes of IgG1. The antibody titers in the hybridoma culture supernatant were 1:128 and 1:256, and those in the ascites fluid were 1:25 600 and 1:32 000, respectively. Western blot analysis and immunohistochemistry showed that the two antibodies can specifically bind with PSMA7 antigen derived from human eu caryotic cells or tissue. Conclusions Two monoclonal antibodies against PSMA7 antigen with high titers and specificity have been successfully prepared. These antibodies can be used for the identification of PSMA7 protein, and may be a useful tool for studying the biological properties of PSMA7 protein.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2008年第2期180-183,共4页 Medical Journal of Chinese People's Liberation Army
基金 国家高技术研究发展计划(863)资助项目(2006AA02A311)
关键词 PSMA7蛋白 杂交瘤 抗体 单克隆 protein PSMA7 hybridomas antibodies, monoclonal
  • 相关文献

参考文献8

  • 1Loomans EE, Roelen AJ, Van Damme HS, et al, Assessment of the functional affinity constant of monoclonal antibodies using an improved enzyme-linked immunosorbent assay. J Immunol Methods, 1995, 184(2):207
  • 2Zhang Z, Torii N, Furusaka A, et al. Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex. J Biol Chem, 2000, 275(20) : 15157
  • 3Kruger M, Beger C, Welch PJ, et al. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry sitemediated translation. Mol Cell Biol, 2001, 21(24): 8357
  • 4Cho S, Choi YJ, Kim JM, et al. Binding and regulation of HIF-lalpha by a subunit of the proteasome complex, PSMA7. FEEBS Lett, 2001, 498(1): 62
  • 5Liu X, Huang W, Li C, et al. Interaction between c-Abl and Arg tyrosine kinases and proteasome subunit PSMA7 regulates proteasome degradation. Mol Cell, 2006, 22(3): 317
  • 6Marusawa H, Matsuzawa S, Welsh K, et al. HBXIP functions as a cofactor of survivin in apoptosis suppressioru EMBO J, 2003, 22 (11): 2729
  • 7Semenza GL. O2-regulated gene expression: transcriptional control of cardio-respiratory physiology by HIF-1. J Appl Physiol, 2004, 96 (3): 1173
  • 8Shi YY, Wang HC, Yin YH, et al. Identification and analysis of tumor-associated antigens in hepatocellular carcinoma. Br J Cancer, 2005, 92(5): 929

同被引文献35

  • 1王琦.三种方法联合检测对阴道炎的诊断意义分析[J].实用医技杂志,2006,13(24):4334-4334. 被引量:1
  • 2Di Maio M, De Maio E, Pen-one F, et al. Hepatocellular carcinoma: systemic treatments [ J ]. J Clin Gastroenterol, 2002, 35 ( 5 Suppl 2 ) :S109- S114.
  • 3Rubin CI, Atweh GF. The role of stathmin in the regulation of the cell cycle [J]. J Cell Biochem,2004, 93(2) :242-250.
  • 4Jeha S, Luo XN, Beran M, et al. Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells [ J]. Cancer Res, 1996,56(6) : 1445-1450.
  • 5Zhang HZ, Wang Y, Gao P,et al. Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells [ J ]. Cancer Biol Ther, 2006, 5 ( 11 ) : 1457-1461.
  • 6Milross CG, Mason KA, Hunter NR, et al. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel [ J ]. J Natl Cancer Inst, 1996, 88(18) : 1308-1314.
  • 7Sawyers C. Targeted cancer therapy [ J ]. Nature, 2004, 432 (7015) : 294-297.
  • 8Cassimeris L. The oncoprotein 18/stathmin family of microtubule destabilizers [J]. Curr Opin Cell Biol, 2002,14( 1 ) : 18-24.
  • 9Gadea BB, Ruderman JV. Aurora B is required for mitotic chromatin-induced phosphorylation of Op18/Stathmin [ J ]. Proc Natl Acad Sci U S A, 2006,103(12) : 4493-4498.
  • 10Tuschl T, Borkhardt A. Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy [ J]. Mol Interv, 2002, 2(3) : 158-167.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部